Last updated: December 5, 2023
Sponsor: Assistance Publique - Hôpitaux de Paris
Overall Status: Active - Recruiting
Phase
N/A
Condition
Autism
Asperger's Disorder
Williams Syndrome
Treatment
Developmental assessment -Parental scales
Qualitative analysis
Baseline sessions TAU
Clinical Study ID
NCT04607616
APHP180671
2019-A02707-50
Ages 18-3 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 18 months to 3 years child at screening
- Child with a diagnosis of Autism Spectrum Disorder (DSM 5) or pervasive DevelopmentalDisorder (ICD 10)
- Child with ADI R and ADOS-2 fulfilling the criteria for TSA / PDD at diagnosis
- Developmental age > 12 months in motility with the Brunet-Lézine test
- Child with availability of parent most present in daily life, only this parentparticipating directly in play sessions
- Signed Informed consent form by both parents
- Patient affiliated to the health insurance system
Exclusion
Exclusion Criteria:
- Level of language in French of parents insufficient to benefit from the care and fillin the questionnaires
- Psychiatric parental pathology interfering with interactions with the child,qualitatively assessed by the referring psychiatrist
- Severe sensory illness of the child (blindness, deafness, degenerative disease)
Study Design
Total Participants: 24
Treatment Group(s): 5
Primary Treatment: Developmental assessment -Parental scales
Phase:
Study Start date:
March 26, 2021
Estimated Completion Date:
January 31, 2026
Study Description
Connect with a study center
Hôpital Saint Eloi
Montpellier, 34000
FranceActive - Recruiting
Hôpital Ville Evrard
Montreuil, 93100
FranceActive - Recruiting
Hôpital Necker Enfants Malades
Paris, 75015
FranceActive - Recruiting
Hôpital Pitié Salpétriere
Paris, 75013
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.